Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-07-01

Clinical Trial Update: Radiochemotherapy With Panitumumab in the Localised Epidermoid Carcinoma of the Anus [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial evaluating radiochemotherapy with Panitumumab for localized anal canal cancer has completed and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Panitumumab (panitumumab)

Snippet

Sponsor: Federation Francophone de Cancerologie Digestive | Conditions: Epidermoid Carcinoma, Anus | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2024-07-01